Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis.

Labrosse, Julie; Osdoit, Marie; Hamy, Anne-Sophie; Coussy, Florence; Pierga, Jean-Yves; Reyal, Fabien; Laas, Enora

Labrosse, Julie; Osdoit, Marie; Hamy, Anne-Sophie; Coussy, Florence; Pierga, Jean-Yves; Reyal, Fabien; Laas, Enora.

Afiliação

Labrosse J; Department of Surgery, Institut Curie, Paris, France.
Osdoit M; Department of Surgery, Institut Curie, Paris, France.
Hamy AS; Translational Research Department, Residual Tumor & Response to Treatment Laboratory, RT2Lab, INSERM, U932 Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.
Coussy F; Department of Medical Oncology, Institut Curie, Paris, France.
Pierga JY; Department of Medical Oncology, Institut Curie, Paris, France.
Reyal F; Department of Surgery, Institut Curie, Paris, France.
Laas E; Translational Research Department, Residual Tumor & Response to Treatment Laboratory, RT2Lab, INSERM, U932 Immunity and Cancer, Institut Curie, PSL Research University, Paris, France.

PLoS One ; 15(6): e0234173, 2020.

Article em En | MEDLINE | ID: mdl-32502222

Assuntos

Neoplasias da Mama/tratamento farmacológico; Período Pré-Operatório; Pontuação de Propensão; Neoplasias da Mama/cirurgia; Quimioterapia Adjuvante; Estudos de Coortes; Intervalo Livre de Doença; Feminino; Humanos; Pessoa de Meia-Idade; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Período Pré-Operatório / Pontuação de Propensão Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google